B. Braun

Executive Summary

B. Braun is a privately-held German medical technology company with over 180 years of history, headquartered in Melsungen. It specializes in the development, manufacture, and sale of medical devices, pharmaceutical products, and healthcare services, with a core focus on infusion therapy, pain therapy, and hospital care. The company operates globally and is known for its commitment to innovation and sustainability. While its private status limits public financial transparency, B. Braun's extensive product portfolio and strong market position in hospital and home care settings underpin its stable revenue base. The company faces competitive pressure from larger players like Baxter and Fresenius but differentiates through a comprehensive system approach integrating devices, disposables, and digital solutions. Continued investments in R&D and strategic acquisitions are expected to drive growth, particularly in emerging markets and connected healthcare technologies.

Upcoming Catalysts (preview)

• Q4 2026European launch of next-generation infusion pump platform80% success
• Q2 2027Strategic acquisition to expand pain therapy portfolio60% success
• Q1 2027FDA 510(k) clearance for connected catheter system70% success